- Home
- POLA vs NURO Comparison
POLA vs NURO Comparison
Compare POLA & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- NURO
- Stock Information
- Founded
- POLA 1979
- NURO 1996
- Country
- POLA United States
- NURO United States
- Employees
- POLA N/A
- NURO N/A
- Industry
- POLA Industrial Machinery/Components
- NURO Medical/Dental Instruments
- Sector
- POLA Miscellaneous
- NURO Health Care
- Exchange
- POLA Nasdaq
- NURO Nasdaq
- Market Cap
- POLA N/A
- NURO 8.2M
- IPO Year
- POLA 2016
- NURO N/A
- Fundamental
- Price
- POLA $0.45
- NURO $4.42
- Analyst Decision
- POLA
- NURO
- Analyst Count
- POLA 0
- NURO 0
- Target Price
- POLA N/A
- NURO N/A
- AVG Volume (30 Days)
- POLA 454.1K
- NURO 14.4K
- Earning Date
- POLA 11-12-2024
- NURO 11-01-2024
- Dividend Yield
- POLA N/A
- NURO N/A
- EPS Growth
- POLA N/A
- NURO N/A
- EPS
- POLA N/A
- NURO N/A
- Revenue
- POLA $11,950,000.00
- NURO $4,383,614.00
- Revenue This Year
- POLA $6.72
- NURO N/A
- Revenue Next Year
- POLA N/A
- NURO N/A
- P/E Ratio
- POLA N/A
- NURO N/A
- Revenue Growth
- POLA N/A
- NURO N/A
- 52 Week Low
- POLA $0.32
- NURO $2.66
- 52 Week High
- POLA $0.98
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- POLA 49.24
- NURO 65.06
- Support Level
- POLA $0.44
- NURO $3.96
- Resistance Level
- POLA $0.54
- NURO $4.69
- Average True Range (ATR)
- POLA 0.07
- NURO 0.22
- MACD
- POLA -0.01
- NURO 0.04
- Stochastic Oscillator
- POLA 20.00
- NURO 82.35
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.